99 related articles for article (PubMed ID: 12627807)
1. CAY-1, a novel antifungal compound from cayenne pepper.
Renault S; De Lucca AJ; Boue S; Bland JM; Vigo CB; Selitrennikoff CP
Med Mycol; 2003 Feb; 41(1):75-81. PubMed ID: 12627807
[TBL] [Abstract][Full Text] [Related]
2. Synergism of CAY-1 with amphotericin B and itraconazole.
De Lucca AJ; Bland JM; Boue S; Vigo CB; Cleveland TE; Walsh TJ
Chemotherapy; 2006; 52(6):285-7. PubMed ID: 17008779
[TBL] [Abstract][Full Text] [Related]
3. CAY-I, a fungicidal saponin from Capsicum sp. fruit.
De Lucca AJ; Bland JM; Vigo CB; Cushion M; Selitrennikoff CP; Peter J; Walsh TJ
Med Mycol; 2002 Apr; 40(2):131-7. PubMed ID: 12058725
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of CAY-1, a saponin from Capsicum frutescens, against Microsporum and Trichophyton species.
Stergiopoulou T; De Lucca AJ; Meletiadis J; Sein T; Boue SM; Schaufele R; Roilides E; Ghannoum M; Walsh TJ
Med Mycol; 2008 Dec; 46(8):805-10. PubMed ID: 18608885
[TBL] [Abstract][Full Text] [Related]
5. Silver enhances the in vitro antifungal activity of the saponin, CAY-1.
De Lucca AJ; Boue S; Sien T; Cleveland TE; Walsh TJ
Mycoses; 2011 Jul; 54(4):e1-9. PubMed ID: 20002309
[TBL] [Abstract][Full Text] [Related]
6. Fungicidal properties of two saponins from Capsicum frutescens and the relationship of structure and fungicidal activity.
De Lucca AJ; Boue S; Palmgren MS; Maskos K; Cleveland TE
Can J Microbiol; 2006 Apr; 52(4):336-42. PubMed ID: 16699584
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activities and cytotoxicity studies of six new azasordarins.
Herreros E; Almela MJ; Lozano S; Gomez de las Heras F; Gargallo-Viola D
Antimicrob Agents Chemother; 2001 Nov; 45(11):3132-9. PubMed ID: 11600368
[TBL] [Abstract][Full Text] [Related]
8. Atropurosides A-G, new steroidal saponins from Smilacina atropurpurea.
Zhang Y; Li HZ; Zhang YJ; Jacob MR; Khan SI; Li XC; Yang CR
Steroids; 2006 Aug; 71(8):712-9. PubMed ID: 16766007
[TBL] [Abstract][Full Text] [Related]
9. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206
[TBL] [Abstract][Full Text] [Related]
10. The in vitro effects of interferon-gamma, alone or in combination with amphotericin B, tested against the pathogenic fungi Candida albicans and Aspergillus fumigatus.
El-Khoury M; Ligot R; Mahoney S; Stack CM; Perrone GG; Morton CO
BMC Res Notes; 2017 Aug; 10(1):364. PubMed ID: 28764751
[TBL] [Abstract][Full Text] [Related]
11. Antifungal jujubogenin saponins from Colubrina retusa.
Li XC; ElSohly HN; Nimrod AC; Clark AM
J Nat Prod; 1999 May; 62(5):674-7. PubMed ID: 10346942
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
Carrillo-Muñoz AJ; Ruesga M; Brio S; del Valle O; Rodriguez V; Santos P; Hernández-Molina JM; Cantón E; Pemán J; Guarro J; Quindós G
Chemotherapy; 2002 Dec; 48(5):224-31. PubMed ID: 12476038
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L.
Soberón JR; Sgariglia MA; Pastoriza AC; Soruco EM; Jäger SN; Labadie GR; Sampietro DA; Vattuone MA
J Ethnopharmacol; 2017 May; 203():233-240. PubMed ID: 28389355
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
15. Biologically active steroidal glycosides from Tribulus terrestris.
Bedir E; Khan IA; Walker LA
Pharmazie; 2002 Jul; 57(7):491-3. PubMed ID: 12168535
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.
Zhang JD; Xu Z; Cao YB; Chen HS; Yan L; An MM; Gao PH; Wang Y; Jia XM; Jiang YY
J Ethnopharmacol; 2006 Jan; 103(1):76-84. PubMed ID: 16169173
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
18. Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates.
te Dorsthorst DT; Verweij PE; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2005 Aug; 49(8):3341-6. PubMed ID: 16048945
[TBL] [Abstract][Full Text] [Related]
19. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazole derivatives.
Foroumadi A; Daneshtalab M; Shafiee A
Arzneimittelforschung; 1999 Dec; 49(12):1035-8. PubMed ID: 10635451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
